TRITACE COMP LS
Tablet, 2.5mg + 12.5mg
RxActive license
Active substance (INN)
hydrochlorothiazideramipril
Pharmaceutical form
Pharmaceutical formTablet
Strength2.5mg + 12.5mg
PackagingUkupno 28 tableta u blisteru (2x14) u kartonskoj kutiji
ManufacturerSanofi S.r.l., Italy
Therapeutic groupCardiovascular system (C09BA05)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateOctober 16, 2025
Analogs in Montenegro
20Other medicines with the same active substance
AMLORAMRx
Capsule, hard, 5mg + 10mgAMLORAMRx
Capsule, hard, 5mg + 5mgAMLORAMRx
Capsule, hard, 2.5mg + 5mgAMLORAMRx
Capsule, hard, 10mg + 5mgAMORARx
Capsule, hard, 10mg + 5mgAMORARx
Capsule, hard, 2.5mg + 5mgAMORARx
Capsule, hard, 5mg + 5mgAMPRILRx
Tablet, 10mgAMPRILRx
Tablet, 2.5mgAMPRILRx
Tablet, 5mgAMPRILRx
Tablet, 1.25mgAMPRIL HDRx
Tablet, 5mg + 25mgAMPRIL HLRx
Tablet, 2.5mg + 12.5mgBELKOMBORx
Capsule, hard, 2.5mg + 2.5mgBELKOMBORx
Capsule, hard, 2.5mg + 1.25mgBELKOMBORx
Capsule, hard, 10mg + 5mgBELKOMBORx
Capsule, hard, 5mg + 2.5mgBELKOMBORx
Capsule, hard, 5mg + 5mgCO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgENAP-HRx
Tablet, 10mg + 25mgSource: CInMED register